NCT04892134 is a clinical trial of blood sample in Multiple Sclerosis, sponsored by Medical University of Graz.

Who is sponsoring NCT04892134?

NCT04892134 is sponsored by Medical University of Graz.

What drugs are being tested in NCT04892134?

Interventions in NCT04892134: blood sample.

What condition does NCT04892134 study?

NCT04892134 studies Multiple Sclerosis.

Is NCT04892134 still recruiting?

NCT04892134 is currently status unknown. Last updated 19 October 2023.

Last reviewed 2023-10-19 · How we verify

NCT04892134

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis

Status unknown Last updated 19 October 2023

What this trial tests

trial testing blood sample in Multiple Sclerosis in 500 participants. Status unknown.

Timeline

3 October 2019

Primary endpoint
31 October 2024

31 October 2025

Quick facts

Lead sponsor	Medical University of Graz
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	3 October 2019
Primary completion	31 October 2024
Estimated completion	31 October 2025
Sites	1 location across Austria

Drugs / interventions tested

blood sample — full drug profile →

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Medical University of Graz

Who can join

Adults 18 to 85, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

By combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtained

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation.
Angiari S, Carlucci T, Budui SL, Bach SD, et al · · 2024 · cited 2× · PMID 39501296 · DOI 10.1186/s12974-024-03270-w
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis.
Ellmeier E, Schnabl A, Meissel J, Stracke A, et al · · 2026 · PMID 42208151 · DOI 10.1016/j.ebiom.2026.106314
Time-Varying Brain Functional Reconfiguration Patterns Associated With Fatigue in Multiple Sclerosis.
Hechenberger S, Broeders TAA, Bet MDA, Helmlinger B, et al · · 2026 · PMID 41797387 · DOI 10.1002/hbm.70480
Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis.
Damulina A, Opriessnig P, Pirpamer L, Demjaha R, et al · · 2025 · PMID 41289552 · DOI 10.1212/wnl.0000000000214433

Verify or expand the search:

Other trials of blood sample

Trials testing the same drug.

NCT07370792 — Contribution of Optical Genome Mapping (OGM) in the Diagnosis of Multiple Congenital Malformations With or Without Intel · NA · recruiting
NCT07273331 — Nursing Needs of Patients With Cirrhosis · enrolling by invitation
NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
NCT06968598 — Analysis of Early Neurodevelopmental Alterations in Bipolar Disorder Based on Cortical Organoid Models · NA · not yet recruiting
NCT07332702 — Long Read Analysis in Spinal Muscular Atrophy - LOREASI · NA · recruiting

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Medical University of Graz trials

Trials by the same sponsor.

NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04892134 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
Last refreshed: 19 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04892134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing